OR WAIT null SECS
August 17, 2023
Fathallah shares his thoughts on the recent DIA 2023 Annual Meeting in Boston, MA.
August 09, 2023
Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.
August 04, 2023
How will AI best be positioned to help safety professionals best utilize their time and resources?
August 03, 2023
"What does the general public not understand the most about clinical trials?" is the question we posed to three industry professionals at DIA 2023.
July 31, 2023
DIA 2023 panel discussed personal experiences in clinical trials and offer suggestions for improvements to focus on the participants.
July 27, 2023
Jaydev Thakkar, chief operating officer, Biofourmis discusses how Biofourmis got involved with the CancerX Initiative at the 2023 DIA annual meeting in Boston, MA.
Jaydev Thakkar, chief operating officer, Biofourmis discusses the work his organization is doing within the CancerX initiative at the 2023 DIA annual meeting in Boston, MA.
Jaydev Thakkar, chief operating officer, Biofourmis gives an overview of the CancerX initiative at the 2023 DIA annual meeting in Boston, MA.
July 10, 2023
Hilde Vanaken, PhD, head, European Forum GCP (EFGCP) eConsent Initiative, and head, TCS Industry Leaders gives an overview of the EFGCP eConsent Initiative at the 2023 DIA annual meeting in Boston, MA.
Hilde Vanaken, PhD, head, European Forum GCP (EFGCP) eConsent Initiative, and head, TCS Industry Leaders gives an overview of eConsent at the 2023 DIA annual meeting in Boston, MA.